Hepatic stellate cells and fibrogenesis in hepatitis C virus infection: An ultrastructural insight

Ultrastructural Pathology

Volumn 34, Issue 2, 2010, Pages 62-67

  Mansy, Soheir S ^a   Elkhafif, Nagwa A ^a   Abelfatah, Ahmed S ^a   Yehia, Hoda A ^a   Mostafa, Ibrahim ^a  

^a THEODOR BILHARZ RESEARCH INSTITUTE   (Egypt)

Author keywords

Electron microscopy; Fibrogenesis; Hepatic fibrosis; Hepatic stellate cells (HSCs); Hepatitis C virus; Myofibroblast like

Indexed keywords

LIPID; VIRUS RNA;

APOPTOSIS; ARTICLE; CHEMISTRY; GENETICS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LIVER CIRRHOSIS; METABOLISM; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; STELLATE CELL; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

APOPTOSIS; HEPACIVIRUS; HEPATIC STELLATE CELLS; HEPATITIS C, CHRONIC; HUMANS; LIPIDS; LIVER CIRRHOSIS; MICROSCOPY, ELECTRON, TRANSMISSION; RNA, VIRAL;

HEPATITIS C VIRUS;

EID: 77749273651     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.3109/01913120903506645     Document Type: Article

References (30)

1. Friedman SL. Stellate cells: a moving target in hepatic fibrogenesis. Hepatology. 2004;40:1041-1043.
2. Olaso E, Ikeda K, Eng FJ, et al. DDR2 receptor promotes MMP-2 mediated proliferation and invasion by hepatic stellate cells. J Clin Invest. 2001;108:1369-1378.
3. Gressner AM; Weiskirchen R. Modern pathogenetic concepts on liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med. 2006;10:76-99.
4. Miyata E, Masuya M, Yoshida S, et al. Hematopoietic origin of hepatic stellate cells in the adult liver. Blood. 2008;111: 2427-2435.
5. Rockey DC. Stellate cell/HCV interactions in hepatic fibrosis. Gastroenterology. 2005;129:2117-2118.
6. Murphy FR, Issa R, Zhou X, et al. Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J Biol Chem. 2002;277:11069-11076.
7. Atzori L, Poli G, Perra A. Hepatic stellate cell: A star cell in the liver. Int J Biochem Cell Biol. 2009;41:1639-1642.
8. Kordes C, Sawitza I, Müller-Marbach A, et al. CD133(1) hepatic stellate cells are progenitor cells. Biochem Biophys Res Commun. 2007;352:410-417.
9. Geerts A. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis. 2001;21:311-35.
10. Tsukamoto H. Epigenetic mechanism of stellate cell trans-differentiation. J Hepatol. 2007;46:352-353.
11. Winau F, Hegasy G, Weiskirchen R, et al. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity. 2007;26:117-129.
12. Friedman SL. Hepatic Stellate cells: protean, multifunctional and enigmatic cells of the liver. Physiol Rev. 2008;88:125-172.
13. Wirz W, Antoine M, Tag CG, et al. Hepatic stellate cells display a functional vascular smooth muscle cell phenotype in a three-dimensional co-culture model with endothelial cells. Differentiation. 2008;76:784-794.
14. Kanzler S, Baumann M, Schirmacher P, et al. Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor β. J Viral Hepatol. 2001;8:430-437.
15. Boeker KH, Haberkorn CI, Michels D, Flemming P, Manns MP, Lichtinghagen R. Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C. Clin Chim Acta. 2002;316:71-81.
16. Mengshol JA, Golden-Mason L, Rosen HR. Mechanisms of disease: HCV-induced liver injury. Nat Clin Pract Gastroenterol Hepatol. 2007;4:622-634.
17. Abdel-Moneim S, Mostafa E, Osam A. circulating matrix metallo-proteinase-1 (MMP-1) and tissue inhibitor metalloproteinase-1 (TIMP-1) as serum markers of liver fibrosis in patients with chronic viral hepatitis. Ar J Gastroenterol. 2008;9:39-43.
18. Carotti S, Morini S, Corradini SG, et al. Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C. Liver Transplant. 2008;14:806-814.
19. Nepomnyashchikh GI, Aidagulova SV, Nepomnyashchikh DL, Kapustina VI, Postnikova OA. Ultrastructural and immuno-histochemical study of hepatic stellate cells over the course of infectious viral fibrosis and cirrhosis of the liver. Bull Exp Biol Med. 2006;142:723-728.
20. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994;19:1513-1520.
21. Brunt EM. Grading and staging the histopathological lesions of chronic hepatitis: The Knodell histology activity index and beyond. Hepatology. 2000;31:241-246.
22. Desmoulière A, Chaponnier C, Gabbiani G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen. 2005;13:7-12.
23. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G. The myofibroblast: one function multiple origins. Am J Pathol. 2007;170:1807-1816.
24. Schürch W, Seemayer TA, Hinz B, Gabbiani G. Myofibroblast. In: Mills SE, ed. Histology for Pathologists. Philadelphia: Lippincott Williams & Wilkins; 2007:125-157.
25. Kobold D, Grundmann A, Piscaglia F, et al. Expression of reelin in hepatic stellate cells and during hepatic tissue repair: a novel marker for the differentiation of HSC from other liver myofibro-blasts. J Hepatol. 2002;36:607-613.
26. Canbay A, Higuchi H, Bronk SF, Taniai M, Sebo TJ, Gores GJ. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology. 2002;123:1323-1330.
27. Canbay A, Friedman S, Gores GJ. Apoptosis: the nexus of liver injury and fibrosis. Hepatology. 2004;39:273-278.
28. Friedman SL. In: Schiff ER, Sorrell MF, Maddrey WC. eds. Schiff's diseases of the liver. Philadelphia: Lippincott Williams & Wilkins; 2003:413-424.
29. Caprino G, Morini S, Franchitto A, et al. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation. Dig Liver Dis. 2005;37:349-356.
30. Tomanovic NR, Boricic IV, Brasanac DC, Stojsic ZM, Delic DC, Brmbolic BJ. Activated liver stellate cells in chronic viral hepatitis: histopathological and immunohistochemical study. J Gastrointest Liver Dis. 2009;18:163-167.